Condition
Total Neoadjuvant Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Total Neoadjuvant Therapy clinical trials that are recruiting, in China. By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Total Neoadjuvant Therapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Short-course pelvic radiotherapy followed by CAPOX (capecitabine + oxaliplatin) and bevacizumab, with or without PD‑1 immunotherapy, for locally advanced rectal cancer. | Phase 2 | Shanghai | Recruiting | Sep 30, 2025 |
| Long-course versus short-course radiotherapy before immunotherapy and total neoadjuvant therapy for locally advanced rectal cancer | Phase 3 | Wuhan, Hubei | Recruiting | Aug 8, 2025 |
| Personalized long-course radiotherapy and chemotherapy, with or without immunotherapy, for locally advanced rectal cancer | Phase 3 | Chengdu, Sichuan | Recruiting | Jun 13, 2025 |
All recruiting trials (3)
-
Short-course pelvic radiotherapy followed by CAPOX (capecitabine + oxaliplatin) and bevacizumab, with or without PD‑1 immunotherapy, for locally advanced rectal cancer.
This trial tests whether adding a PD‑1 immunotherapy to short-course radiotherapy followed by CAPOX and bevacizumab helps adults with locally advanced rectal cancer get a higher complete response rate and fewer distant metastases.
-
Long-course versus short-course radiotherapy before immunotherapy and total neoadjuvant therapy for locally advanced rectal cancer
This trial tests whether adding immunotherapy to total neoadjuvant therapy and using short-course versus long-course radiotherapy improves outcomes for adults with locally advanced rectal cancer.
-
Personalized long-course radiotherapy and chemotherapy, with or without immunotherapy, for locally advanced rectal cancer
This study tests whether adding the immunotherapy drug serplulimab to personalized long-course radiotherapy and chemotherapy helps adults with locally advanced rectal cancer achieve complete tumor disappearance.
Related topics
Quick answers
How many Total Neoadjuvant Therapy clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.